Zobrazeno 1 - 10
of 414
pro vyhledávání: '"van de Waterbeemd B"'
Autor:
Hoonakker, M.E., Verhagen, L.M., van der Maas, L., Metz, B., Uittenbogaard, J.P., van de Waterbeemd, B., van Els, C.A.C.M., van Eden, W., Hendriksen, C.F.M., Sloots, A., Han, W.G.H.
Publikováno v:
In Vaccine 17 August 2016 34(37):4429-4436
Autor:
Hoonakker, M E, Verhagen, L M, van der Maas, L, Metz, B, Uittenbogaard, J P, van de Waterbeemd, B, van Els, C A C M, van Eden, W, Hendriksen, C F M, Sloots, A, Han, W G H
Whole cell Bordetella pertussis (wP) vaccines are still used in many countries to protect against the respiratory disease pertussis. The potency of whole-cell pertussis vaccine lots is determined by an intracerebral challenge test (the Kendrick test)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::98ab6dedaaf65627d7ad148ae4fcb389
https://dspace.library.uu.nl/handle/1874/345486
https://dspace.library.uu.nl/handle/1874/345486
Autor:
van de Waterbeemd, B.
Only vaccines containing outer membrane vesicles (OMV) have successfully stopped Neisseria meningitidis serogroup B epidemics. The OMV vaccines, however, provide limited coverage and are difficult to produce. This is caused by an obligatory detergent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9a612ee828f58841e394ae07f4e34ac0
https://research.wur.nl/en/publications/next-generation-outer-membrane-vesicle-vaccines-from-concept-to-c
https://research.wur.nl/en/publications/next-generation-outer-membrane-vesicle-vaccines-from-concept-to-c
Autor:
Gerritzen MJH; Institute for Translational Vaccinology (Intravacc), Process Development Bacterial Vaccines, P.O. Box 450, 3720, AL, Bilthoven, The Netherlands.; Bioprocess Engineering, Wageningen University, P.O. Box 16, 6700, AA, Wageningen, The Netherlands., Stangowez L; Institute for Translational Vaccinology (Intravacc), Process Development Bacterial Vaccines, P.O. Box 450, 3720, AL, Bilthoven, The Netherlands., van de Waterbeemd B; Institute for Translational Vaccinology (Intravacc), Process Development Bacterial Vaccines, P.O. Box 450, 3720, AL, Bilthoven, The Netherlands.; Dept. Drug Substance Development, Janssen Vaccines and Prevention, Archimedesweg 4-6, 2333, CN, Leiden, The Netherlands., Martens DE; Bioprocess Engineering, Wageningen University, P.O. Box 16, 6700, AA, Wageningen, The Netherlands., Wijffels RH; Bioprocess Engineering, Wageningen University, P.O. Box 16, 6700, AA, Wageningen, The Netherlands.; Faculty of Biosciences and Aquaculture, Nord University, P.O. Box 1409, 8049, Bodø, Norway., Stork M; Institute for Translational Vaccinology (Intravacc), Process Development Bacterial Vaccines, P.O. Box 450, 3720, AL, Bilthoven, The Netherlands. michiel.stork@intravacc.nl.
Publikováno v:
Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2019 Dec; Vol. 103 (23-24), pp. 9401-9410. Date of Electronic Publication: 2019 Nov 01.
Autor:
Streefland, M., Van Herpen, P.F.G., Van de Waterbeemd, B., Van der Pol, L.A., Beuvery, E.C., Tramper, J., Martens, D.E., Toft, M.
Publikováno v:
Biotechnology & Bioengineering; Oct2009, Vol. 104 Issue 3, p492-504, 13p
Autor:
Li, Ning1 (AUTHOR) 15179421660@163.com, Wu, Minghui1 (AUTHOR), Wang, Lu1 (AUTHOR), Tang, Mengyu1 (AUTHOR), Xin, Hongbo1 (AUTHOR), Deng, Keyu1 (AUTHOR) lining@ncu.edu.cn
Publikováno v:
Membranes. Jun2024, Vol. 14 Issue 6, p135. 14p.
Autor:
Wu, Tao1 (AUTHOR) wutao@tjcu.edu.cn, Jiang, Jingjing1 (AUTHOR), Zhang, Hongyang1 (AUTHOR), Liu, Jiazhi1 (AUTHOR), Ruan, Haihua1 (AUTHOR) ruanhaihua@tjcu.edu.cn
Publikováno v:
Microbial Cell Factories. 5/25/2024, Vol. 23 Issue 1, p1-13. 13p.
Autor:
Li, Changchang1,2 (AUTHOR), Xue, Heng1,2 (AUTHOR), Du, Xinjing1 (AUTHOR), Nyaruaba, Raphael1,2 (AUTHOR), Yang, Hang1,2 (AUTHOR), Wei, Hongping1,2 (AUTHOR) hpwei@wh.iov.cn
Publikováno v:
Journal of Nanobiotechnology. 5/21/2024, Vol. 22 Issue 1, p1-17. 17p.
Autor:
Hassan, Duaa1, Kheiruralla, Inas Abbass2, Jasim, Maysoon Kooshi2, Hadi, Ameer Mezher3, Al-Mawlah, Yasir Haider3 Yasser.almawla@uobabylon.edu.iq
Publikováno v:
Journal of Biotech Research. 2024, Vol. 17, p105-111. 7p.
Autor:
Metz B; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., Hoonakker M; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., Uittenbogaard JP; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., Weyts M; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., Mommen GP; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., Meiring HD; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., Tilstra W; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., Pennings JL; National Institute for Public Health and the Environment , P.O. Box 1, 3720 BA Bilthoven, The Netherlands., van der Pol LA; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., Kuipers B; National Institute for Public Health and the Environment , P.O. Box 1, 3720 BA Bilthoven, The Netherlands., Sloots A; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., van den IJssel J; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., van de Waterbeemd B; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands., van der Ark A; Institute for Translational Vaccinology (Intravacc) , P.O. Box 450, 3720 AL Bilthoven, The Netherlands.
Publikováno v:
Journal of proteome research [J Proteome Res] 2017 Feb 03; Vol. 16 (2), pp. 528-537. Date of Electronic Publication: 2016 Dec 23.